These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 10622182)
41. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. Ikonomov OC; Manji HK Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159 [TBL] [Abstract][Full Text] [Related]
42. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518 [TBL] [Abstract][Full Text] [Related]
43. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice. Böer U; Cierny I; Krause D; Heinrich A; Lin H; Mayr G; Hiemke C; Knepel W Neuropsychopharmacology; 2008 Sep; 33(10):2407-15. PubMed ID: 18046304 [TBL] [Abstract][Full Text] [Related]
44. Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study. Soares JC; Chen G; Dippold CS; Wells KF; Frank E; Kupfer DJ; Manji HK; Mallinger AG Psychiatry Res; 2000 Aug; 95(2):109-18. PubMed ID: 10963797 [TBL] [Abstract][Full Text] [Related]
45. Lithium treatment inhibits protein kinase C translocation in rat brain cortex. Wang HY; Johnson GP; Friedman E Psychopharmacology (Berl); 2001 Oct; 158(1):80-6. PubMed ID: 11685387 [TBL] [Abstract][Full Text] [Related]
46. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment. Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726 [TBL] [Abstract][Full Text] [Related]
47. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Manji HK; Lenox RH Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897 [TBL] [Abstract][Full Text] [Related]
48. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Chen G; Manji HK Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219 [TBL] [Abstract][Full Text] [Related]
49. Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders. Manji HK; Chen G Curr Psychiatry Rep; 2000 Dec; 2(6):479-89. PubMed ID: 11122999 [TBL] [Abstract][Full Text] [Related]
50. Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization. Müller-Oerlinghausen B Compr Psychiatry; 2000; 41(2 Suppl 1):26-31. PubMed ID: 10746901 [TBL] [Abstract][Full Text] [Related]
51. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. Zarate CA; Manji HK CNS Drugs; 2009; 23(7):569-82. PubMed ID: 19552485 [TBL] [Abstract][Full Text] [Related]
52. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium. Lin YF; Huang MC; Liu HC J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822 [TBL] [Abstract][Full Text] [Related]
53. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Pandey GN; Dwivedi Y; SridharaRao J; Ren X; Janicak PG; Sharma R Neuropsychopharmacology; 2002 Feb; 26(2):216-28. PubMed ID: 11790517 [TBL] [Abstract][Full Text] [Related]
54. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Li X; Friedman AB; Zhu W; Wang L; Boswell S; May RS; Davis LL; Jope RS Biol Psychiatry; 2007 Jan; 61(2):216-22. PubMed ID: 16806104 [TBL] [Abstract][Full Text] [Related]
55. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. Wada A J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950 [TBL] [Abstract][Full Text] [Related]
56. Cade's observation of the antimanic effect of lithium and early Australian research. Burrows GD; Tiller JW Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S27-31. PubMed ID: 10622176 [TBL] [Abstract][Full Text] [Related]
57. The early European lithium studies. Schou M Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S39-47. PubMed ID: 10622179 [TBL] [Abstract][Full Text] [Related]
58. A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance? Abrial E; Lucas G; Scarna H; Haddjeri N; Lambás-Señas L Mol Neurobiol; 2011 Dec; 44(3):407-19. PubMed ID: 21983961 [TBL] [Abstract][Full Text] [Related]
59. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795 [TBL] [Abstract][Full Text] [Related]
60. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator. Machado-Vieira R J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]